Literature DB >> 8319436

Biotin labelling of chicken antibodies and their subsequent use in ELISA and immunohistochemistry.

M Olovsson1, A Larsson.   

Abstract

Avian antibodies have many advantages to mammalian antibodies due to the phylogenetic differences between birds and mammals, resulting in an increased sensitivity and a decreased background in many immunological assays. Since the avidin-biotin system is an efficient detection system for antibodies with a high sensitivity, we wanted to investigate the activity and unspecific binding of optimally biotin labelled chicken antibodies in ELISA and immunohistochemistry. We report on the conditions for biotinylation of chicken antibodies and that optimally biotinylated antibodies show a high activity and a low background in both ELISA and immunohistochemistry.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8319436     DOI: 10.1016/0147-9571(93)90007-r

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  3 in total

1.  Ecto-enzymes activities in splenic lymphocytes of mice experimentally infected by Trypanosoma cruzi and treated with specific avian immunoglobulins: an attempt to improve the immune response.

Authors:  Thirssa H Grando; Matheus D Baldissera; Guilherme Do Carmo; Camila B Oliveira; Eduarda T Santi; Pedro Henrique Doleski; Daniela B R Leal; Lenita Moura Stefani; Ricardo E Mendes; Aleksandro S Da Silva; Silvia G Monteiro
Journal:  Mol Cell Biochem       Date:  2018-02-12       Impact factor: 3.396

Review 2.  Avian IgY antibodies and their recombinant equivalents in research, diagnostics and therapy.

Authors:  Edzard Spillner; Ingke Braren; Kerstin Greunke; Henning Seismann; Simon Blank; Dion du Plessis
Journal:  Biologicals       Date:  2012-06-28       Impact factor: 1.856

Review 3.  IgY: a promising antibody for use in immunodiagnostic and in immunotherapy.

Authors:  Wilmar Dias da Silva; Denise V Tambourgi
Journal:  Vet Immunol Immunopathol       Date:  2010-01-07       Impact factor: 2.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.